Global Antiulcerant Drugs Market: Overview

Antiulcerant drugs are a wide class of drugs used in treating ulcers of the stomach and intestine. Some of the popular antiulcerant drugs used currently are H2 receptor antagonists, gastric mucosal protective drugs, antacids, and antibiotics. They are also used as proton pump inhibitors as co-treatment in patients with the risk of gastrointestinal bleeding events such as those taking aspirin. Their use prevents the production of gastric acid by stomach and lower part of abdomen. The rising instance of heartburn and indigestion caused by the production of excess stomach acid has helped antiulcerant drugs occupy significant role in the treatment of stomach ulcers. Some antiulcerant drugs are also gaining popularity in the treatment of diarrhea or address an irritable gastrointestinal tract in patients.

The various evaluations of the growth dynamics of the global antiulcerant drugs market will offer insights and projections for emerging as well as new entrants to help them tap into lucrative avenues. The assessments can guide interested participants to know recent investment of prominent players on research and development of new drugs.

Global Antiulcerant Drugs Market: Trends and Opportunities

There has been rising awareness about ulcer diseases, which has been imparting an increasing momentum to the evolution of the antiulcerant drugs market. The pipeline of promising antiulcerant drugs has been rising over the past few years in various parts of the world. In recent years, the pharmacology of antiulcerant drugs has received considerable attention by pharmaceutical companies, which has helped them develop drugs with better clinical results. The rising incidence of peptide ulcers, especially in people with sedentary lifestyle, is also catalyzing the growth of the global antiulcerant drugs market. The rising acceptance of antacids in anti-ulcer agents among the patient population for symptomatic relief is also a significant boosting the market.

There is prevalence of infection with H. pylori in communities with the lack of access to clean water and proper sewage systems. This if untreated may lead to peptic ulcer disease, and antiulcerant drugs play crucial role in the treatment. The growing mortality of thrombotic events, especially in tuberculosis patients, is also likely to accentuate prospects of the antiulcerant drugs market in the coming few years. The rising risk of adverse cardiovascular events related to patients treated with aspirin has fueled the uptake of antiulcerant drugs. In recent years, several pharmaceuticals have been actively working to adopt advanced technologies for manufacturing anatacids. Moreover, they are spending sizeable sums on accelerating their drug pipelines. This will open new, exciting avenues in the global market.

Global Antiulcerant Drugs Market: Regional Outlook

The report on the global antiulcerant drugs market offers a critical assessment of key regional growth dynamics and lucrative avenues in emerging markets. The study also assesses the growth potential of these regions and the trends that will fuel their expansion over the next few years. Regionally, developed regions, notably North America, might generate copious amounts of revenue to the global antiulcerant drugs market. The trend will be supported by the substantial uptake of advanced drug manufacturing technologies in the regions. On the other hand, Asia Pacific is one of the regions that show great potential in the near future. One of the several factors that may contribute to the rising demand for antiulcerant drugs in the region is the growing prevalence of diabetes.

Global Antiulcerant Drugs Market: Competitive Landscape

The study takes a closer look at recent strategies and drug development initiatives made by various players in the global antiulcerant drugs market. It also highlights major investment measures taken by established players. Some of the prominent companies in the antiulcerant drugs market are Takeda Pharmaceutical, Eisai, Daewoong Pharmaceutical, Allergan, and AstraZeneca plc.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Antiulcerant Drugs Market

Pre Book